Sai Parenterals acquiring majority stake in Bion

The acquisition will add 16 established brands and around 250 field staff, strengthening its presence in India’s prescription market, Sai Parenterals said.
More news in Industry
Mumbai luxury housing market shifts towards larger 4 BHK homes
Wipro 3D ties up with Markforged to expand industrial 3D printing in India
Amazon to invest $7 billion in India renewables by 2030
Rupee rises 43 paise to close at 93.51 (provisional) against U.S. dollar